- Home
- G vs CAI Comparison
G vs CAI Comparison
Compare G & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- G
- CAI
- Stock Information
- Founded
- G 1997
- CAI 2008
- Country
- G Bermuda
- CAI United States
- Employees
- G N/A
- CAI N/A
- Industry
- G Professional Services
- CAI Medical Specialities
- Sector
- G Consumer Discretionary
- CAI Health Care
- Exchange
- G Nasdaq
- CAI Nasdaq
- Market Cap
- G 7.2B
- CAI 8.5B
- IPO Year
- G 2007
- CAI 2025
- Fundamental
- Price
- G $38.93
- CAI $30.61
- Analyst Decision
- G Buy
- CAI Strong Buy
- Analyst Count
- G 7
- CAI 6
- Target Price
- G $49.57
- CAI $35.50
- AVG Volume (30 Days)
- G 1.6M
- CAI 627.9K
- Earning Date
- G 11-06-2025
- CAI 11-05-2025
- Dividend Yield
- G 1.76%
- CAI N/A
- EPS Growth
- G N/A
- CAI N/A
- EPS
- G 3.01
- CAI N/A
- Revenue
- G $4,929,034,000.00
- CAI $533,847,000.00
- Revenue This Year
- G $7.51
- CAI $64.66
- Revenue Next Year
- G $6.69
- CAI $45.81
- P/E Ratio
- G $12.81
- CAI N/A
- Revenue Growth
- G 7.40
- CAI 106.53
- 52 Week Low
- G $37.49
- CAI $25.40
- 52 Week High
- G $56.76
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- G 40.44
- CAI N/A
- Support Level
- G $37.49
- CAI N/A
- Resistance Level
- G $40.07
- CAI N/A
- Average True Range (ATR)
- G 0.64
- CAI 0.00
- MACD
- G 0.02
- CAI 0.00
- Stochastic Oscillator
- G 44.81
- CAI 0.00
About G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.